Login
← Go Back
Dishman Carbogen Amcis
DCAL · Pharma > Pharmaceuticals & Drugs · Chairman: Janmejay R Vyas · MD: Arpit J Vyas · Listing date: Sept. 22, 2017 · Employees: 929 · Ahmedabad · http://imdcal.com
Stock Price vs Company Growth
1d
2.7%
1w
2.2%
1m
14.5%
3m
23.4%
6m
13.0%
1y
47.6%
5y
7.8%
all
9.2%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 146 2.7%
145
201
Company Overview
Sales
2,901 Cr
Growth: 8.7%
Profit after Tax
16.2 Cr
Growth: -83.4%
Small Cap
2,284 Cr
P/E: 141.5x
Industry P/E: 32.5x
Fundamentals
Sales (Cr) ₹ 2,901
Growth 8.7%
EBITDA 16.7%
P/S 0.8x
Dividend 0.0%
P/E 141.5x
Book Value ₹ 422
PEG Ratio 16.3x
ROE 0.3%
P/B 0.3x
Shareholding Pattern
Institutions
L And T Mutual Fund Trustee Ltd-L And T Flexicap Fund
2.9 %
Mukul Agrawal
2.55 %
Government Pension Fund Global
2.33 %
Aditya Birla Sun Life Trustee Private Limited A/C Aditya Birla Sun Life Flexi Cap Fund
1.88 %
Hbm Healthcare Investment(Cayman) Ltd.
1.62 %
Promoters
Adimans Technologies Llp
59.32 %
Others
Increase    Decrease    No change
Company Profile Detailed
The company is a fully integrated CRAMS player working with global pharmaceutical innovators. It has a global presence with development and manufacturing facilities across Europe, India, and China. It provides end-to-end, integrated, high-value, niche CRAMS offering, right from process research & development to late-stage clinical and commercial manufacturing facilities along with the supply of Active Pharmaceutical Ingredients (API) to innovator pharmaceutical companies.
Belongs to (12 Indices) view more
Investors (53)
tata.bal...
icici.pr...
jhunjhun...
Followers (1)
varsha96